News item

New start-up Patholyt will bring AI research into pathology diagnostics

Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Patholyt is a spin-off from Radboudumc, a frontrunner in computational pathology research.

Pathology is pivotal in the diagnostic process of many diseases such as cancer. For more than 100 years pathologists have been using the optical microscope for tissue examination. The field of pathology is now challenged by the world’s shortage of pathologists, and the growing requirements for efficiency and consistent quality.

A revolution in the field

Recent progress in artificial intelligence, imaging, and high-performance computing has unlocked a revolution in the field: AI-powered Computational Pathology. Patholyt will bring research algorithms into clinical practice to both speed up and improve the quality of pathology diagnostics.

Read more at the website of Radboudumc.

Share this news

Share on facebook
Share on twitter
Share on linkedin

Fighting malaria is fighting poverty

Diseases that spread across the globe come and go, but malaria has been around for thousands of years. The number of people affected by the disease is on the rise and it hits lower-income countries the hardest. So how can we fight malaria, and what will it bring to the world if we manage to do so? Koen Dechering, CEO of TropIQ Health Sciences, explains why more needs to be done and how his company contributes to eradicating the disease once and for all.

Read More »

Subscribe the NTC Newsletter

We care about your privacy: Read more

Settle at Novio Tech Campus!

Connect with Novio Tech Campus!